Amrutanjan Health Care Ltd
Amrutanjan Health Care Ltd Q4 FY24 Results & Presentation Highlights: Revenue, Margins & Order Book
Q4 FY24 investor presentation: what the company reported on revenue, margins and projects.
Based on Amrutanjan Health Care Ltd's Q4 FY24 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.
The short version
Q4 FY24 Net Sales: - OTC: ₹108.37 Cr, up 27.57% YoY (Q4 FY23: ₹84.95 Cr) - Comfy: ₹31.11 Cr, up 59.87% YoY (Q4 FY23: ₹19.46 Cr) - Beverages: ₹18.67 Cr, up 25.81% YoY (Q4 FY23: ₹14.84 Cr) - Ele Quarterly Financials (Q4 FY24 vs Q4 FY23): - Operating Profit (approximate from Operating Profit % on page 24): FY24 Operating Profit % is 10.89% vs 10.36% in FY23 (year-on-year increase of 0.53 ppt).
From Amrutanjan Health Care Ltd's Q4 FY24 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Q4 FY24 Net Sales:
- OTC: ₹108.37 Cr, up 27.57% YoY (Q4 FY23: ₹84.95 Cr)
- Comfy: ₹31.11 Cr, up 59.87% YoY (Q4 FY23: ₹19.46 Cr)
- Beverages: ₹18.67 Cr, up 25.81% YoY (Q4 FY23: ₹14.84 Cr)
- Electro Plus: ₹17.56 Cr, up 37.29% YoY (Q4 FY23: ₹12.79 Cr)
- FY24 Net Sales:
- OTC: ₹380.39 Cr, up 10.22% YoY (FY23: ₹345.11 Cr)
- Comfy: ₹108.26 Cr, up 37.63% YoY (FY23: ₹78.66 Cr)
- Beverages: ₹39.98 Cr, up 23.17% YoY (FY23: ₹32.46 Cr)
- Electro Plus: ₹33.75 Cr, up 25.75% YoY (FY23: ₹26.84 Cr)
- Volume Growth:
- Head category volume growth: 3.9%
- Body category volume growth: 7%
- Back Pain Roll-on volume growth: 20.5%
- Outlook:
- Target revenue of ₹1000 Cr by FY28
2 more points management made on revenue & sales performance
Profitability & Margins
See what Amrutanjan Health Care Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
Top-ranked in Pharmaceuticals & Biotechnology
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Amrutanjan Health Care Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
Amrutanjan Health Care Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹150 Cr, net profit ₹16 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Amrutanjan Health Care Ltd's management said in earlier quarters
Others in Pharmaceuticals & Biotechnology this season
- Bharat Parenterals Ltd (Q4 FY24)
For Q4 FY 2024, consolidated revenue from operations was INR 67.82 crore, up 13.4% YoY (Q4 FY 2023: INR 59.82 crore). Key investor presentation takeaways from B
- Themis Medicare Ltd (Q4 FY24)
97.82 Cr, up 22.11% YoY from Rs. Key investor presentation takeaways from Themis Medicare Ltd's Q4 FY24 investor presentation — and how it ranks against sector
- Fermenta Biotech Ltd (Q4 FY24)
Q4-FY24 Consolidated Operational Revenue: INR 973 Mn, down 7.5% YoY (Page 11) . Key investor presentation takeaways from Fermenta Biotech Ltd's Q4 FY24 investor
Frequently Asked Questions
What were Amrutanjan Health Care Ltd Q4 FY24 results?
Q4 FY24 Net Sales: - OTC: ₹108.37 Cr, up 27.57% YoY (Q4 FY23: ₹84.95 Cr) - Comfy: ₹31.11 Cr, up 59.87% YoY (Q4 FY23: ₹19.46 Cr) - Beverages: ₹18.67 Cr, up 25.81% YoY (Q4 FY23: ₹14.84 Cr) - Ele Quarterly Financials (Q4 FY24 vs Q4 FY23): - Operating Profit (approximate from Operating Profit % on page 24): FY24 Operating Profit % is 10.89% vs 10.36% in FY23 (year-on-year increase of 0.53 ppt).
What is Amrutanjan Health Care Ltd share price analysis?
Amrutanjan Health Care Ltd currently shows a neutral. The stock trades at a P/E of 22.9 with a market cap of ₹1,428 Cr. Investors should review the full earnings analysis for detailed insights.
Is Amrutanjan Health Care Ltd planning capital expenditure?
The provided investor presentation does not mention any details regarding capex, capacity expansion, new plants, or new projects.
Keep Amrutanjan Health Care Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.